Advertisement

Society of Interventional Radiology Position Statement: Prostate Artery Embolization for Treatment of Benign Disease of the Prostate

      Prostatic artery embolization (PAE) is a promising new treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). It has therefore garnered much interest in the interventional community. This article will review the scientific background for this therapy, describe the current devices available for treatment, and state the position of the Society of Interventional Radiology (SIR) with regard to the study and potential adoption of this therapy.

      Abbreviations:

      BPH (benign prostatic hyperplasia), IPSS (International Prostate Symptom Score), LUTS (lower urinary tract symptoms), PAE (prostatic artery embolization), TURP (transurethral resection of the prostate)
      To read this article in full you will need to make a payment
      SIR Member Login
      Society Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Wei J.T.
        • Calhoun E.
        • Jacobsen S.J.
        Urologic diseases in America project: benign prostatic hyperplasia.
        J Urol. 2005; 173: 1256-1261
        • McVary K.T.
        • Roehrborn C.G.
        • Avins A.L.
        • et al.
        Update on AUA guideline on the management of benign prostatic hyperplasia.
        J Urol. 2011; 185: 1793-1803
        • Thomas A.W.
        • Cannon A.
        • Bartlett E.
        • et al.
        The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction.
        J Urol. 2005; 174: 1887-1891
        • Mebust W.K.
        • Holtgrewe H.L.
        • Cockett A.T.
        • Peters P.C.
        Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients.
        J Urol. 2002; 167: 999-1003
        • Sandhu J.S.
        • Ng C.
        • Vanderbrink B.A.
        • et al.
        High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates.
        Urology. 2004; 64: 1155-1159
        • Westenberg A.
        • Gilling P.
        • Kennett K.
        • et al.
        Holmium laser resection of the prostate versus transurethral resection of the prostate: results of a randomized trial with 4-year minimum long-term followup.
        J Urol. 2004; 172: 616-619
        • Kacker R.
        • Williams S.B.
        Endourologic procedures for benign prostatic hyperplasia: review of indications and outcomes.
        Urol J. 2011; 8: 171-176
        • Camara-Lopes G.
        • Mattedi R.
        • Antunes A.A.
        • et al.
        The histology of prostate tissue following prostatic artery embolization for the treatment of benign prostatic hyperplasia.
        Int Braz J Urol. 2013; 39: 222-227
        • Mitchell M.E.
        • Waltman A.C.
        • Athanasoulis C.A.
        • Kerr W.S.
        • Dretler S.P.
        Control of massive prostatic bleeding with angiographic techniques.
        J Urol. 1976; 115: 692-695
        • Bischoff W.
        • Goertler U.
        Successful intra-arterial embolization of bleeding carcinoma of the prostate.
        Urologe A. 1977; 16: 99-102
        • Michel F.
        • Dubruille T.
        • Cercueil J.P.
        • Paparel P.
        • Cognet F.
        • Krause D.
        Arterial embolization for massive hematuria following transurethral prostatectomy.
        J Urol. 2002; 168: 2550-2551
        • Rastinehad A.R.
        • Caplin D.M.
        • Ost M.C.
        • et al.
        Selective arterial prostatic embolization (SAPE) for refractory hematuria of prostatic origin.
        Urology. 2008; 71: 181-184
        • DeMeritt J.S.
        • Elmasri F.F.
        • Esposito M.P.
        • Rosenberg G.S.
        Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization.
        J Vasc Interv Radiol. 2000; 11: 767-770
        • Sun F.
        • Sanchez F.M.
        • Crisostomo V.
        • et al.
        Benign prostatic hyperplasia: transcatheter arterial embolization as potential treatment—preliminary study in pigs.
        Radiology. 2008; 246: 783-789
        • Sun F.
        • Sánchez F.M.
        • Crisóstomo V.
        • et al.
        Transarterial prostatic embolization: initial experience in a canine model.
        AJR Am J Roentgenol. 2011; 197: 495-501
        • Carnevale F.C.
        • Antunes A.A.
        • da Motta Leal Filho J.M.
        • et al.
        Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients.
        Cardiovasc Intervent Radiol. 2010; 33: 355-361
        • Pisco J.M.
        • Pinheiro L.C.
        • Bilhim T.
        • Duarte M.
        • Mendes J.R.
        • Oliveira A.G.
        Prostatic arterial embolization to treat benign prostatic hyperplasia.
        J Vasc Interv Radiol. 2011; 22: 11-19
        • Pisco J.M.
        • Pinheiro L.C.
        • Bilhim T.
        • et al.
        Prostatic arterial embolization for benign prostatic hyperplasia: short- and intermediate-term results.
        Radiology. 2013; 266: 668-677
        • Pisco J.M.
        • Tinto H.R.
        • Pinheiro L.C.
        • et al.
        Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up.
        Eur Radiol. 2013; 23: 2561-2572
        • Pisco J.M.
        • Tinto H.R.
        • Pinheiro L.C.
        • et al.
        Erratum to: Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up.
        Eur Radiol. 2013; 23: 2573-2574
        • Carnevale F.C.
        • da Motta-Leal-Filho J.M.
        • Antunes A.A.
        • et al.
        Quality of life and symptoms relief support prostatic artery embolization for patients with acute urinary retention due to benign prostatic hyperplasia.
        J Vasc Interv Radiol. 2012; 24: 535-542
        • Bagla S.
        • Cooper J.M.
        • Rholl K.S.
        • et al.
        Early findings from a prospective US trial: prostatic artery embolization (PAE) in the treatment of benign prostatic hypertrophy (BPH).
        J Vasc Interv Radiol. 2013; 24: S74-S75
        • Bagla S.
        • Martin C.P.
        • van Breda A.
        • et al.
        Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia.
        J Vasc Interv Radiol. 2014; 25: 47-52
        • Gao Y.A.
        • Huang Y.
        • Zhang R.
        • et al.
        Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate—a prospective, randomized, and controlled clinical trial.
        Radiology. 2014; 270: 920-928
        • Burnett A.L.
        • Wein A.J.
        Benign prostatic hyperplasia in primary care: what you need to know.
        J Urol. 2006; 175: S19-S24
        • Pereira J.A.
        • Bilhim T.
        • Duarte M.
        • Rio Tinto H.
        • Fernandes L.
        • Pisco J.M.
        Patient selection and counseling before prostatic arterial embolization.
        Tech Vasc Interv Radiol. 2012; 15: 294-299
        • Bilhim T.
        • Pisco J.M.
        • Rio Tinto H.
        • et al.
        Unilateral versus bilateral prostatic arterial embolization for lower urinary tract symptoms in patients with prostate enlargement.
        Cardiovasc Intervent Radiol. 2013; 36: 403-411
        • Bilhim T.
        • Pisco J.M.
        • Rio Tinto H.
        • et al.
        Prostatic arterial supply: anatomic and imaging findings relevant for selective arterial embolization.
        J Vasc Interv Radiol. 2012; 23: 1403-1415
        • Brook O.R.
        • Faintuch S.
        • Brook A.
        • Goldberg S.N.
        • Rofsky N.M.
        • Lenkinski R.E.
        Embolization therapy for benign prostatic hyperplasia: influence of embolization particle size on gland perfusion.
        J Magn Reson Imaging. 2013; 38: 380-387
        • Golzarian J.
        • Antunes A.A.
        • Bilhim T.
        • et al.
        Prostatic artery embolization to treat lower urinary tract symptoms related to benign prostatic hyperplasia and bleeding in patients with prostate cancer: proceedings from a multidisciplinary research consensus panel.
        J Vasc Interv Radiol. 2014; 25: 665-674